Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04252014 · ClinicalTrials.gov registry record · NA
Optimizing Hookah Tobacco Public Education Messages to Reduce Young Adult Use
A NA study of Hookah Tobacco Smoking, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 830
- Enrollment target
- 1
- Study location
NCT04252014 is a NA study of Hookah Tobacco Smoking that has completed, run by Georgetown University. The registered enrollment target is 830 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04252014, a NA study of Hookah Tobacco Smoking, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 830 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 2-arm randomized controlled trial to test the effects of hookah tobacco public education messages among young adults who are susceptible non-users of hookah tobacco and those who are current hookah tobacco users. The primary outcomes are hookah tobacco use behavior (initiation among baseline susceptible non-users, frequency of use and cessation among baseline current users) at 6-month follow-up. Secondary outcomes are curiosity to use hookah tobacco (susceptible non-users) and motivation to quit using hookah tobacco (current hookah users) measured at 6-month follow-up. These outcomes will also be measured at 2- and 4-month follow-up time points.
Conditions Studied
Interventions
- BEHAVIORAL Hookah tobacco messages
Study Locations (1)
District of Columbia
- Georgetown University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 830 participants |
| Start Date | 2020-02-04 |
| Est. Completion | 2022-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04252014
The ClinicalTrials.gov registry entry for NCT04252014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 830 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hookah Tobacco Smoking appearing as the primary indexed condition, and to 1 intervention - of which Hookah tobacco messages is the first listed.
NCT04252014 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04252014 about?
NCT04252014 is a clinical study titled "Optimizing Hookah Tobacco Public Education Messages to Reduce Young Adult Use". This is a 2-arm randomized controlled trial to test the effects of hookah tobacco public education messages among young adults who are susceptible non-users of hookah tobacco and those who are current hookah tobacco users. The primary outcomes are hookah tobacco use behavior (initiation among baseli...
What is the current status of trial NCT04252014?
This trial is currently completed. It is a NA study. The enrollment target is 830 participants. The study started on 2020-02-04. Estimated completion is 2022-04-30.
What conditions does trial NCT04252014 study?
This clinical trial studies the following conditions: Hookah Tobacco Smoking.
What interventions are being tested in trial NCT04252014?
The interventions under investigation include: Hookah tobacco messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT04252014?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04252014 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.